259 related articles for article (PubMed ID: 30577833)
1. New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer.
Holub K; Biete A
BMC Cancer; 2018 Dec; 18(1):1280. PubMed ID: 30577833
[TBL] [Abstract][Full Text] [Related]
2. Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients.
Holub K; Biete A
Clin Transl Oncol; 2019 Jul; 21(7):836-844. PubMed ID: 30470994
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the mechanisms of immune evasion in pancreatic cancer: may it be a systemic inflammation responsible for dismal survival?
Holub K; Conill C
Clin Transl Oncol; 2020 Jan; 22(1):81-90. PubMed ID: 31004253
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy.
Holub K; Busato F; Gouy S; Sun R; Pautier P; Genestie C; Morice P; Leary A; Deutsch E; Haie-Meder C; Biete A; Chargari C
J Clin Med; 2020 May; 9(5):. PubMed ID: 32408668
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.
Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA
Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
Vrede SW; van Weelden WJ; Visser NCM; Bulten J; van der Putten LJM; van de Vijver K; Santacana M; Colas E; Gil-Moreno A; Moiola CP; Mancebo G; Krakstad C; Trovik J; Haldorsen IS; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; van der Wurff AA; Matias-Guiu X; Amant F; ; Snijders MPLM; Küsters-Vandevelde HVN; Reijnen C; Pijnenborg JMA
Gynecol Oncol; 2021 Jun; 161(3):787-794. PubMed ID: 33858677
[TBL] [Abstract][Full Text] [Related]
7. Blood-based prognostic biomarkers in Crohn's Disease patients on biologics: a promising tool to predict endoscopic outcomes.
Crispino F; Grova M; Maida M; Renna S; Mocciaro F; Casà A; Rizzuto G; Tesè L; Scimeca D; Di Mitri R; Macaluso FS; Orlando A
Expert Opin Biol Ther; 2021 Aug; 21(8):1133-1141. PubMed ID: 34042009
[TBL] [Abstract][Full Text] [Related]
8. The analysis of the prognostic value of the neutrophil/ lymphocyte ratio and the platelet/lymphocyte ratio among advanced endometrial cancer patients.
Muzykiewicz KP; Iwanska E; Janeczek M; Glanowska I; Karolewski K; Blecharz P
Ginekol Pol; 2021; 92(1):16-23. PubMed ID: 33448001
[TBL] [Abstract][Full Text] [Related]
9. Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?
Vrede SW; Donkers H; Reijnen C; Smits A; Visser NCM; Geomini PM; Ngo H; van Hamont D; Pijlman BM; Vos MC; Snijders MPLM; Kruitwagen R; Bekkers RLM; Galaal K; Pijnenborg JMA
J Obstet Gynaecol; 2024 Dec; 44(1):2294332. PubMed ID: 38186008
[TBL] [Abstract][Full Text] [Related]
10. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
[TBL] [Abstract][Full Text] [Related]
11. Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.
Bendifallah S; Ouldamer L; Lavoue V; Canlorbe G; Raimond E; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Gynecol Oncol; 2017 Jan; 144(1):107-112. PubMed ID: 27789083
[TBL] [Abstract][Full Text] [Related]
12. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
13. Assessment of patients with nasal polyposis by the neutrophil-to-lymphocyte ratio and eosinophil-to-lymphocyte ratio.
Yenigün A
Kulak Burun Bogaz Ihtis Derg; 2015; 25(4):193-9. PubMed ID: 26211858
[TBL] [Abstract][Full Text] [Related]
14. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer].
Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334
[TBL] [Abstract][Full Text] [Related]
15. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.
Cummings M; Merone L; Keeble C; Burland L; Grzelinski M; Sutton K; Begum N; Thacoor A; Green B; Sarveswaran J; Hutson R; Orsi NM
Br J Cancer; 2015 Jul; 113(2):311-20. PubMed ID: 26079303
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic Cancer.
Ohkuma R; Kubota Y; Horiike A; Ishiguro T; Hirasawa Y; Ariizumi H; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Aoki T; Murakami M; Kobayashi S; Tsunoda T; Wada S
Pancreas; 2021 Feb; 50(2):167-175. PubMed ID: 33565793
[TBL] [Abstract][Full Text] [Related]
18. Pre- and postoperative blood neutrophil-to-lymphocyte and eosinophil-to-lymphocyte ratios in patients with sinonasal polyps: A preliminary investigation.
Brescia G; Barion U; Zanotti C; Parrino D; Marioni G
Allergy Asthma Proc; 2017 Sep; 38(5):64-69. PubMed ID: 28814353
[TBL] [Abstract][Full Text] [Related]
19. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.
Ethier JL; Desautels DN; Templeton AJ; Oza A; Amir E; Lheureux S
Gynecol Oncol; 2017 Jun; 145(3):584-594. PubMed ID: 28222899
[TBL] [Abstract][Full Text] [Related]
20. The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ-Ⅲ colorectal cancer.
Wei Y; Zhang X; Wang G; Zhou Y; Luo M; Wang S; Hong C
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e243-e251. PubMed ID: 29532611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
